Medicine Description oxyprogest 150 mg/ml
oxyprogest 150 mg/ml vial is a medication that combines medroxyprogesterone, a synthetic progestin, and oxybutynin, an antimuscarinic agent. Medroxyprogesterone functions by binding to progesterone receptors in target tissues, modulating gene expression, and thereby influencing the menstrual cycle and alleviating symptoms of endometriosis. It helps in regulating the proliferation of endometrial tissue, thereby reducing pain and other symptoms associated with endometriosis. Oxybutynin acts selectively on the smooth muscle of the bladder by inhibiting the action of acetylcholine at muscarinic receptors, resulting in reduced bladder contractions and increased bladder capacity, which assists patients with urinary incontinence or overactive bladder symptoms.
Indications and Uses of oxyprogest 150 mg/ml vial
- Management of endometriosis-related pain
- Treatment of symptoms associated with overactive bladder
- Hormone replacement therapy in specific clinical scenarios
Side Effects of oxyprogest 150 mg/ml vial
- Dizziness or lightheadedness
- Dry mouth
- Constipation
- Nausea
- Fatigue
- Weight gain
- Headaches
Storage and Handling
Store at controlled room temperature, between 20°C to 25°C (68°F to 77°F). Protect from light and moisture. Do not freeze. Keep out of reach of children.
Patient Advice and Precautions
Patients should be advised to report any unusual changes in mood or signs of depression. Staying adequately hydrated can help alleviate dry mouth. It is essential to consult a healthcare provider before discontinuing the medication or if experiencing severe side effects. Regular follow-up appointments are recommended to monitor the therapy's effectiveness and adjust as necessary.